Alpha Tau Medical
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 12 in the most recent period (2026/Q3).
- Total institutional ownership rose 2.6 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 27.34% +2.64pp
- Institutions
- 93 +12
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-05-12
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
41 filings tracked · 0 buys · 16 sells
| Name | Role | Stake |
|---|---|---|
| Michael Avruch | Director | 1.64% |
| Yona Keisari | Chief Scientific Officer | 0.55% |
| Raphi Levy | Chief Financial Officer | 0.10% |
| David Milch | Independent Director | 0.10% |
| Samuel Blumenfeld | Independent Director | 0.05% |
| Ruth Alon | Independent Director | -- |
| Alan Adler | Independent Director | -- |
| Nadav Kidron | Director | -- |
| Maya Racine-Netser | Independent Director | -- |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-08-20 | Raphi Levy | Chief Financial Officer | Derivative Exercise and Sale | -2,871 | $2.98–15.00 |
| 2026-08-10 | Raphi Levy | Chief Financial Officer | Derivative Exercise and Sale | -17,730 | $2.98–14.00 |
| 2026-07-05 | Raphi Levy | Chief Financial Officer | Derivative Exercise and Sale | -2,270 | $2.98–14.00 |
| 2026-07-01 | Raphi Levy | Chief Financial Officer | Derivative Exercise and Sale | -17,873 | $2.98–13.00 |
| 2026-06-30 | Raphi Levy | Chief Financial Officer | Derivative Exercise and Sale | -2,127 | $2.98–13.02 |
| 2026-06-29 | Raphi Levy | Chief Financial Officer | Open Market Disposition | -20,000 | $12.00 |
| 2026-06-24 | Raphi Levy | Chief Financial Officer | Open Market Disposition | -20,000 | $11.00 |
| 2026-06-22 | Raphi Levy | Chief Financial Officer | Open Market Disposition | -17,500 | $9.47–10.00 |
| 2026-06-02 | Raphi Levy | Chief Financial Officer | Open Market Disposition | -32,500 | $10.76–10.90 |
| 2026-03-17 | Ruth Alon | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Alan Adler | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | David Milch | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Samuel Blumenfeld | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Nadav Kidron | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Maya Racine-Netser | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Raphi Levy | Chief Financial Officer | Initial Statement of Beneficial | 0 | -- |
| 2026-03-17 | Michael Avruch | Director | Initial Statement of Beneficial | 0 | -- |
| 2026-02-24 | Raphi Levy | Chief Financial Officer | Intent to Sell (Form 144) | -10,000 | $7.40 |
| 2026-01-12 | Raphi Levy | Chief Financial Officer | Intent to Sell (Form 144) | -15,000 | $7.09 |
| 2026-01-08 | Raphi Levy | Chief Financial Officer | Intent to Sell (Form 144) | -25,000 | $6.41 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 20:02:23 · For reference only, not investment advice and not tailored to your situation.
Alpha Tau Medical discussion 0 comments